Mount Sinai New York — New York, New York

Mount Sinai New York is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai New York has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Stroke, Ischemic, Heart Failure, Heart Failure With Reduced Ejection Fraction.

Sponsors: Penumbra Inc., Impulse Dynamics, Abbott Medical Devices.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai New York?

Mount Sinai New York has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai New York conducted?

Mount Sinai New York has 4 clinical trials on record, with 1 currently active. Their work covers Stroke, Ischemic, Heart Failure, Heart Failure With Reduced Ejection Fraction.

Is Mount Sinai New York accredited by Crixeo Health?

Yes — Mount Sinai New York holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mount Sinai New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.